7 $1 billion-plus drugs seen reaching market in 2016
Roche's Avastin Fails in Early-Stage Colon Cancer Study
Roche Announces Cost-Cutting Plan
Roche Backs Aileron's Stapled Peptide Technology in $1.1 Billion Deal
FDA to Review Use of Avastin for Breast Cancer
Roche's Diabetes Drug Trouble Is a Shot in the Arm for Amylin
Roche Sales Grow on Cancer Drug Demand
Type 2 diabetes: Roche says its weekly drug works better than Merck's daily one
Novartis is making a multipronged push into China
How a con artist stole millions from Procter & Gamble and Roche
Roche Holdings' third-world discount: benevolence or bottom-line?
Mega mergers return with pharma, tech buying sprees
What would a swine flu pandemic do to the economy?
Fear of flu epidemic hurts stocks, helps some drug companies
Roche's Genentech buy could kill a technology leader
Genentech's great deal